The relationship between cerebral vascular disease and parkinsonism: The VADO study

Parkinsonism and Related Disorders

Volumn 18, Issue 6, 2012, Pages 775-780

  Antonini, A ^a,b   Vitale, C ^c,d   Barone, P ^d,e   Cilia, R ^a   Righini, A ^a   Bonuccelli, U ^f   Abbruzzese, G ^g   Ramat, S ^h   Petrone, A ⁱ   Quatrale, R ^j   Marconi, R ^k   Ceravolo, R ^f   Stefani, A ^l   Lopiano, L ^m   Zappia, M ⁿ   Capus, L ^o   Morgante, L ^p   Tamma, F ^q   Tinazzi, M ^r   Colosimo, C ^s   Guerra, U P ^t   Valzania, Franco ^u   Fagioli, Giorgio ^u   Distefano, Angela ^v   Bagnato, Antonio ⁱ   Feggi, Luciano ^w   Anna, S ^x   Maria Teresa Rosaria De Cristofaro, ^h   Nobili, Flavio ^g   Mazzuca, Nicola ^k   Baldari, Sergio ^p   Eleopra, Roberto ^y   Bestetti, Alberto ^q   Benti, Riccardo ^z   Varrone, Andrea ^aa   Volterrani, Duccio ^f   Massa, Rita ^ab   Stocchi, Fabrizio ^ac   Schillaci, Orazio ^l   Dore, Franca ^o   Zibetti, Maurizio ^m   Castellano, Giancarlo ^ad   Battista, S Giovanni ^ae   Giorgetti, Giorgio ^r   more..

^a PARKINSON INSTITUTE   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

^d IDC Hermitage Capodimonte   (Italy)

^e UNIVERSITY OF SALERNO   (Italy)

^f UNIVERSITY OF PISA   (Italy)

^g UNIVERSITY OF GENOA   (Italy)

^h UNIVERSITY OF FLORENCE   (Italy)

ⁱ ANNUNZIATA HOSPITAL   (Italy)

^j UNIVERSITY OF FERRARA   (Italy)

^k MISERICORDIA HOSPITAL   (Italy)

^l UNIVERSITY OF ROME TOR VERGATA   (Italy)

^m UNIVERSITY OF TURIN   (Italy)

ⁿ UNIVERSITY OF CATANIA   (Italy)

^o UNIVERSITY OF TRIESTE   (Italy)

^p UNIVERSITY OF MESSINA   (Italy)

^q SAN PAOLO HOSPITAL   (Italy)

^r UNIVERSITY OF VERONA   (Italy)

^s SAPIENZA UNIVERSITY OF ROME   (Italy)

^t OSPEDALI RIUNITI   (Italy)

^u BELLARIA HOSPITAL   (Italy)

^v INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^w Division of Nuclear Medicine   (Italy)

^x UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^y Ospedale Umberto I   (Italy)

^z FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^aa CNR   (Italy)

^ab SAPIENZA UNIVERSITY OF ROME   (Italy)

^ac IRCCS SAN RAFFAELE PISANA   (Italy)

^ad NONE   (Italy)

^ae Hospital   (Italy)

more..

Author keywords

Dopamine transporter SPECT imaging; MR imaging; Parkinson's disease; Vascular parkinsonism

Indexed keywords

DOPAMINE TRANSPORTER; LEVODOPA;

ADULT; AGED; ARTICLE; BASAL GANGLION; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; FRONTAL LOBE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROTEIN BINDING; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VASCULAR LESION; VASCULAR PARKINSONISM;

AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; CEREBROVASCULAR DISORDERS; COHORT STUDIES; CORPUS STRIATUM; CROSS-SECTIONAL STUDIES; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; LEVODOPA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARKINSON DISEASE; PARKINSONIAN DISORDERS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84862186620     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2012.03.017     Document Type: Article

References (30)

1. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. The accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathologic study. J Neurol Neurosurg Psychiatry 1992, 55:181-184.
2. Rektor I., Rektorova I., Kubova D. Vascular parkinsonism - an update. J Neurol Sci 2006, 248:185-191.
3. Fitzgerald P.M., Jankovic J. Lower body parkinsonism: evidence for vascular etiology. Mov Disord 1989, 4:249-260.
4. Winikates J., Jankovic J. Clinical correlates of vascular parkinsonism. Arch Neurol 1999, 56:98-102.
5. Zijlmans J.C., Daniel S.E., Hughes A.J., Révész T., Lees A.J. Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord 2004, 19(6):630-640.
6. Zijlmans J., Katzenschlager R., Daniel S., Lees A. The L-dopa response in vascular parkinsonism. J Neurol Neurosurg Psychiatry 2004, 75:545-547.
7. Awad I.A., Spetzler R.F., Hodak J.A., Awad C.A., Carey R. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly, I: correlation with age and cerebrovascular risk factors. Stroke 1986, 17:1084-1089.
8. Booij J., Speelman J.D., Horstink M.W., Wolters E.C. The clinical benefit of imaging striatal transporters with [123I]FP-CIT SPECT in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism. Eur J Nucl Med 2001, 28:266-272.
9. 123I]beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease. Mov Disord 2002, 17:518-523.
10. Eerola J., Tienari P.J., Kaakkola S., Nikkinen P., Launes J. How useful is [123I]beta- CIT SPECT in clinical practice?. J Neurol Neurosurg Psychiatry 2005, 76:1211-1216.
11. Scherfler C., Schwarz J., Antonini A., Grosset D., Valldeoriola F., Marek K., et al. Role of DAT-SPECT in the diagnostic work up of Parkinsonism. Mov Disord 2007, 22(9):1229-1238.
12. Gelb D.J., Oliver E., Gilman S. Diagnostic criteria for Parkinson's disease. Arch Neurol 1999, 56:33-39.
13. Grosset K., Needleman F., Macphee G., Grosset D. Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table. Mov Disord 2004, 19(11):1370-1374.
14. Fahn S., Elton R.L., Members of the UPDRS Development Committee Unified Parkinson's disease rating scale. Recent developments in Parkinson's disease 1987, vol. 2:153-164. Macmillan Health Care Information, Florham Park, NJ.
15. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 1967, 17(5):427-442.
16. Piccini P., Pavese N., Canapicchi R., Paoli C., Del Dotto P., Puglioli M., et al. White matter hyperintensities in Parkinson's disease. Arch Neurol 1995, 52:191-194.
17. Litvan I., Bhatia K.P., Burn D.J., Goetz C.G., Lang A.E., McKeith I., et al. Movement Disorders Society Scientific issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 2003, 18(5):467-486.
18. Scheltens P., Barkhof F., Leys D., Pruvo J.P., Nauta J.J., Vermersch P., et al. A semiquantitative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 1993, 114:7-12.
19. Kapeller P., Barber R., Vermeulen R.J., Adèr H., Scheltens P., Freidl W., et al. Visual rating of age-related white matter changes on magnetic resonance imaging: scale comparison, interrater agreement, and correlations with quantitative measurements. Stroke 2003, 34:441-445.
20. Ottaviani S., Tinazzi M., Pasquin I., Nothdurfter W., Tomelleri G., Fincati E., et al. Comparative analysis of visual and semi-quantitative assessment of striatal [(123)I]FP-CIT-SPET binding in Parkinson's disease. Neurol Sci 2006, 27(6):397-401.
21. Yamanouchi H., Nagura H. Neurological signs and frontal white matter lesions in vascular parkinsonism. A clinicopathologic study. Stroke 1997, 28:965-969.
22. Rampello L., Alvano A., Battaglia G., Raffaele R., Vecchio I., Malaguerra M. Different clinical and evolutional patterns in late idiopathic and vascular parkinsonism. J Neurol 2005, 252:1045-1049.
23. van Swieten J.C., van den Hout J.H.W., van Ketel B.A., Hijdra A., Wokke J.H., van Gijn J. Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. Brain 1991, 114:761-774.
24. 123I] FP-CIT SPECT study in vascular parkinsonism and Parkinson's disease. Mov Disord 2007, 22(9):1278-1285.
25. Lorberboym M., Djaldetti R., Melamed E., Sadeh M., Lampl Y. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism. J Nucl Med 2004, 45(10):1688-1693.
26. Alarcón F., Zijlmans J.C., Dueñas G., Cevallos N. Post-stroke movement disorders: report of 56 patients. J Neurol Neurosurg Psychiatry 2004, 75(11):1568-1574.
27. Forno L.S. Reaction of the substantia nigra to massive basal ganglia infarction. Acta Neuropathol 1983, 62(1-2):96-102.
28. Peralta C., Werner P., Holl B., Kiechl S., Willeit J., Seppi K., et al. Parkinsonism following striatal infarcts: incidence in a prospective stroke unit cohort. J Neural Transm 2004, 111:1473-1483.
29. Kahn U., Porteous L., Hassan A., Markus H.S. Risk factor profile of cerebral small vessel disease and its subtypes. J Neurol Neurosurg Psychiatry 2007, 78:702-706.
30. Rektor I., Goldemund D., Sheardova K., Rektorova I., Michalcova Z., Dufek M. Vascular pathology in patients with idiopathic Parkinson's disease. Parkinsonism Relat Disord 2009, 15:24-29.